Treatment of hypertension after renal transplantation: Long-term efficacy of verapamil, enalapril, and doxazosin

Kidney International, Supplement

Volumn 54, Issue 68, 1998, Pages

  Martinez Castelao, A ^a   Hueso, M ^a   Sanz, V ^a   Rejas, J ^a   Alsina, J ^a   Grinyo, J M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

ACE inhibitors; Alpha blockers; Blood pressure; Calcium channel blockers; Cyclosporine; Graft survival; Post transplant hypertension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; VERAPAMIL; ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; STATISTICAL ANALYSIS; TACHYCARDIA; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DRUG EFFECT; GRAFT SURVIVAL; HYPERCHOLESTEROLEMIA; LONGITUDINAL STUDY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RENOVASCULAR HYPERTENSION;

ADULT; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DOXAZOSIN; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; VERAPAMIL;

EID: 0031740870     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.06826.x     Document Type: Article

References (29)

1. P.J. Held F.K. Ort C.R. Blagg L.Y. Agodoa Survival and mortality excerpts from United States Renal Data System 1990 Annual Report Am J Kidney Dis 16 Suppl 2 1990 44 52
2. P. Mc Enery G. Arbus D. Stablein A. Tejani Renal transplantation in children N Engl J Med 326 1992 1727 1732
3. R.G. Luke Pathophysiology and treatment of posttransplant hypertension J Am Soc Nephrol 2 Suppl 1 1991 S37 S44
4. C. Bachy G.P.J. Alexandre van Ypersele C. de Striou Hypertension after renal transplantation Br Med J 2 1987 1287
5. J.J. Curtis Cyclosporin-induced hyertension J.H. Laragh B.M. Brenner Hypertension; Pathophysiology, Diagnosis and Management 1990 Raven Press Ltd New York 1829 1835
6. M.K. Jarowenko S.M. Flechner C.T. Van Buren M.I. Lorber B.D. Kahan Influence of cyclosporin on post transplant blood pressure response Am J Kidney Dis 10 1987 98 103
7. D.V. Hamilton D.J.S. Carmichael D.B. Evans R.Y. Calne Hypertension in renal transplanted recipients on cyclosporin A and corticosteroids and azathioprine Transplant Proc 14 1982 597 600
8. C. Ponticelli G. Montagnino Causes of arterial hypertension in kidney transplantation Contrib Nephrol 54 1987 226 230
9. M.R. First J.F. Neylan L.L. Rocher A. Tejani Hypertension after renal transplantation J Am Soc Nephrol 4 Suppl 1 1994 S29 S34
10. J.J. Curtis Treatment of hypertension in renal allograft patients: Does drug selection make a difference? Kidney Int 52 Suppl 63 1997 S75 S77
11. S. Harihanan T.J. Schroeder P. Weiskittel J.W. Alexander M.R. First Prednisone withdrawal in HLA identical and one-haplotype-matched live-related donor and cadaver renal transplant recipients Kidney Int 44 Suppl 43 1993 S30 S35
12. J.M. Morales A. Andres C. Prieto B. Ortuño J. Estenoz C. Dorado J. Arenas L.M. Ruilope L. Fernaandezruz J.L. Rodicio Calcium antagonists treatment minimizes early cyclosporin nephrotoxicity in renal transplantation. A prospective randimized trial Trasnsplant Proc 21 1989 1537 1539
13. The FK-506 Kidney Transplant Multicenter Study Group FK506 in kidney transplantation: Results of the US Randomized Comparative Phase III Study Satellite Symposium of the 15th Annual Meeting of the American Society of Transplant Physicians May 1996 Dallas
14. F. Moreso, D. Seron, A.I. Anunciada, M. Hueso, J.M. Ramon, X. Fulladosa, S. Gil-Vernet, J. Alsina, J.M. Grinyo Recipient body surface area as a predictor of post-transplant renal allograft evolution. Transplantation (in press)
15. M.I. McHugh H. Tanboga R. Marcen F. Liaño V. Robson R. Willkinson Hypertension following renal transplantation Q J Med 49 1980 395 The role of host’s kidneys
16. E. Guidi G. Bianchi V. Dallosta A. Cantaluppi F. Mandelli E. Polli Influence of familial hypertension of the donor on the blood pressure and antihypertensive therapy of kidney graft recipients Nephron 30 1982 318 323
17. T.D. Mountokalakis The renal consequences of arterial hypertension Kidney Int 51 1997 1639 1653
18. Joint National Committee On Detection, Evaluation And Treatment Of High Blood Pressure The fifth report of the Joint National Committee on Detection, Evaluation and treatment of High Blood pressure (JNC V) Arch Intern Med 153 1993 154 183
19. D. Grekas C. Dioudis I. Kalevrosogloum P. Alivanis V. Derveniotis A. Ourkantonis Renal hemodynamics in hypertensive renal allograft recipients: Effect of calcium antagonists and angiotensin-converting-enzyme inhibitors Kidney Int 49 Suppl 55 1996 S97 S100
20. G. Navis D. deZeeuw P.E. deJong ACE-inhibitors. Panacea for progressive renal disease? Lancet 349 1997 1852 1853
21. J. Chalmers Treatment guidelines in hypertension: Current limitations and future solutions J Hypertens 14 Suppl 4 1996 S3 S8
22. E. Ritz Are antihypertensive drugs similar in protecting the kidney? Am J Hypertens 8 Suppl 1 1995 53S 58S
23. T. Lenz F.B. Muller J.E. Sotelo J.H. Largah P. August Hemodynamic responses to verapamil monotherapy in patients with renal disease Am J Hypertens 4 1991 939 943
24. D.B.N. Lee Cyclosporine and the renin-angiotensin axis Kidney Int 52 1997 248 260
25. A.M. Castelao J.M. Grinyo J.M. Galceran E. Andres S. Gil-Vernet D. Seron A. Martinez-Amenos J. Alsina Estudio comparativo de los antagonsitas del calcio (verapamil) versus inhibidores del enzima de conversiñ-n de la angiotensina (enalapril) en el tratameinto de la hipertensi-n arterial post trasplante renal bajo inmunosupresion con cisclosporina Nefrología 13 Suppl 2 1993 47 51
26. G. Mourad J. Ribstein A. Mimran Converting-enzyme inhibitor versus calciumantagonist in cyclosporine-treated renal transplants Kidney Int 43 1983 419 425
27. R.T. Gansevoort W.J. Sluiter M.H. Hemmelder D. De Zeeuw P.E. De Jong Antiproteinuric effect of blood-pressure-lolwering agents: Meta-analysis of comparative trials Nephrol Dial Transplant 10 1995 1963 1974
28. D.D. Maki J.Z. Ma T.A. Louis B.L. Kasiske Long-term effects of antihypertensive agents on proteinuria and renal function Arch Intern Med 155 1995 1073 1080
29. H.L. Elliot The case for alfa1-aderenocepter antagonists as first-line antihypertensive agents J Hum Hypertens 5 1991 309 311